 G Protein-coupled receptors
|
|
Ion channels
|
|
Nuclear receptors
|
|
 Protein kinases
|
Serine/threonine kinases
|
AGC group
|
PRKCA [HSA:5578] [KO:K02677]
|
PRKCB [HSA:5579] [KO:K19662]
|
PRKCG [HSA:5582] [KO:K19663]
|
PRKCD [HSA:5580] [KO:K06068]
|
PRKCE [HSA:5581] [KO:K18050]
|
PRKCH [HSA:5583] [KO:K18051]
|
PRKCQ [HSA:5588] [KO:K18052]
|
AURK [HSA:6790 9212 6795] [KO:K11481 K11479 K11480]
|
AURKA [HSA:6790] [KO:K11481]
|
AURKB [HSA:9212] [KO:K11479]
|
AKT (PKB) [HSA:207 208 10000] [KO:K04456]
|
 D11371 Capivasertib (JAN/USAN) <JP/US>
D06221 Triciribine phosphate (USAN)
D10381 Afuresertib (USAN/INN)
D10382 Afuresertib hydrochloride (USAN)
D10641 Ipatasertib (USAN/INN)
D10674 Uprosertib (USAN/INN)
D11074 Ipatasertib hydrochloride (JAN)
D11409 Miransertib (USAN/INN)
D11508 Miransertib mesylate (USAN)
|
DMPK [HSA:1760] [KO:K08788]
|
ROCK [HSA:6093 9475] [KO:K04514 K17388]
|
ROCK2 [HSA:9475] [KO:K17388]
|
CAMK group
|
CK1 group
|
CMGC group
|
STE group
|
TKL group
|
Other
|
Receptor serine/threonine kinases (RSTK)
|
Receptor tyrosine kinases (RTK)
|
Non-receptor tyrosine kinases
|
|
Peptidases and inhibitors
|
|
Cytokines and receptors
|
|
Cell surface molecules and ligands
|
|
Transporters
|
|
Enzymes
|
|
Nucleic acids
|
|
Not elsewhere classified
|
Target-based Classification of Drugs